文献速递免疫规划传染病防控与疫情报告

墨尔本HIV感染者流感疫苗接种率2015-2025年重复横断面研究

Influenza vaccination uptake among people living with HIV in Melbourne, 2015-2025: a repeated cross-sectional study.
PubMed 文献 · Vaccine · 2026-08-13

该研究在墨尔本性健康中心对2015-2025年18,879例HIV感染者记录进行重复横断面分析,发现诊所内流感疫苗接种率为39.6%,疫情前逐年上升,新冠后显著下降并部分恢复。调整外部接种后估计接种率为58.6%,提示仅凭诊所记录低估真实接种率。

要点

  • HIV感染者流感疫苗接种率仍不理想,2025年为40.1%。
  • 新冠疫情期间接种 odds 较预期低65.5%,此后年增20.3%。
  • 纳入外部接种后调整接种率为58.6%,诊所记录低估真实水平。

核心结论

  • 墨尔本HIV感染者流感疫苗接种率仍不理想,且受新冠疫情影响而中断。
  • 外部接种贡献显著,仅凭诊所记录会低估真实接种率。

研究设计与样本

  • 对2015-2025年就诊于墨尔本性健康中心的HIV感染者进行重复横断面分析,共18,879条记录。
  • 采用分段logistic回归评估新冠前后趋势,并随机抽取1100例未接种者病历审查原因。

主要发现

  • 18,879例HIV感染者中位年龄42岁(IQR 34-53),39.6%(7474/18,879)在诊所接种流感疫苗。
  • 接种率从2015年40.4%(527/1305)升至2019年46.7%(779/1667),2021年降至22.9%(388/1691),2025年部分恢复至40.1%(891/2221)。
  • 疫情前接种率每年增加4.8%(95%CI:2.3-7.4,p<0.001)。
  • 新冠疫情后接种 odds 较预期低65.5%(95%CI:60.9-69.7,p<0.001),此后每年增加20.3%(95%CI:16.7-24.0)。
  • 1100例未接种者中,40.6%(447)无记录原因,31.8%(350)报告在别处接种,13.5%(146)拒绝;调整外部接种后接种率为58.6%(11,058/18,879)。

临床怎么用

  • 应加强接种提醒和标准化记录,并整合澳大利亚免疫登记系统以优化预防保健和接种数据捕获。

局限性

  • 接种状态主要基于诊所内接种记录,可能低估真实接种率;未接种原因中40.6%无记录。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People living with HIV (PLHIV) are at increased risk of severe influenza-related complications, and annual vaccination is recommended. Uptake remains suboptimal and Australian data are limited. We assessed influenza vaccination uptake among PLHIV at a Melbourne specialist clinic and explored reasons for non-vaccination. METHODS: We conducted a repeated cross-sectional analysis of PLHIV attending the Melbourne Sexual Health Centre (MSHC), 2015-2025. Vaccination status was based on vaccines administered at the clinic. Segmented logistic regression assessed trends before and after the COVID-19 pandemic. A random sample of 1100 unvaccinated individuals (100/year) underwent chart review to identify reasons for non-vaccination, and an adjusted estimate incorporated self-reported external vaccination. RESULTS: Among 18,879 PLHIV records (median age 42, IQR 34-53), 39.6% (7474/18,879) were vaccinated at MSHC. Uptake rose from 40.4% (527/1305) in 2015 to 46.7% (779/1667) in 2019, fell to 22.9% (388/1691) in 2021, and partially recovered to 40.1% (891/2221) in 2025. Pre-pandemic uptake increased 4.8% annually (95% CI: 2.3-7.4, p < 0.001). After COVID-19 onset, vaccination odds were 65.5% lower than expected (95% CI: 60.9-69.7, p < 0.001), with subsequent annual increases of 20.3% (95% CI: 16.7-24.0). Of 1100 unvaccinated individuals reviewed, 40.6% (447) had no documented reason, 31.8% (350) reported vaccination elsewhere, and 13.5% (146) declined. Adjusted uptake including external vaccination was 58.6% (11,058/18,879). CONCLUSIONS: Influenza vaccination uptake among PLHIV in Melbourne remains suboptimal and was disrupted by the COVID-19 pandemic. External vaccination contributes substantially, so clinic records alone underestimate true uptake. Improved prompts, standardised documentation, and integration with the Australian Immunisation Register may optimise preventive care and better capture vaccination delivery.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Rafizadeh A, Wijekoon D, Aung ET, et al. Influenza vaccination uptake among people living with HIV in Melbourne, 2015-2025: a repeated cross-sectional study. Vaccine. 2026. PMID: 42594643. doi:10.1016/j.vaccine.2026.129038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。